Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

28. September 2017 13:42 ET | Quelle: Biodesix, Inc.; The Society for Advanced Bronchoscopy

Introducing The Society For Advanced Bronchoscopy

TAMPA, Fla., Sept. 28, 2017 (GLOBE NEWSWIRE) -- The Society for Advanced Bronchoscopy announced its inception and plans for its first annual meeting today, citing the need to “promote and support...
20. September 2017 11:17 ET | Quelle: Biodesix, Inc.

Study Published In Managed Care Regarding Prognostic and Cancer-Care Planning Value of Biodesix’s VeriStrat® Proteomic Test

BOULDER, Colo., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Findings published in the peer-reviewed journal Managed Care showed that prognostic information provided by the Biodesix® VeriStrat test can...
15. September 2017 11:55 ET | Quelle: Biodesix, Inc.

Interim Results from Biodesix® Study Indicate That VeriStrat Testing Impacts Treatment Decisions Across All Stages of Non-Small Cell Lung Cancer

BOULDER, Colo., Sept. 15, 2017 (GLOBE NEWSWIRE) -- Interim analysis of a new study examining the impact of VeriStrat testing on treatment decisions in patients with non-small cell lung cancer...
08. August 2017 13:17 ET | Quelle: Biodesix, Inc.

Biodesix Presents Cell-free DNA Process Optimization for Liquid Biopsy Test

BOULDER, Colo., Aug. 08, 2017 (GLOBE NEWSWIRE) -- In two separate talks, Biodesix scientists presented information on further development and improvement of laboratory processes used for the...
10. Juli 2017 13:09 ET | Quelle: Biodesix, Inc.

Lung Cancer: VeriStrat® Test Identifies Patients with Squamous Cell Carcinoma of the Lung Who Are More Likely to Have Improved Survival on Afatinib Therapy

BOULDER, Colo., July 10, 2017 (GLOBE NEWSWIRE) -- Clinical findings published in the peer reviewed journal Lung Cancer show that the Biodesix® VeriStrat test is prognostic for outcomes in patients...
12. Juni 2017 12:37 ET | Quelle: Biodesix, Inc.

Biodesix® and Positive Bioscience Announce Partnership to Bring Cancer Tests to India

BOULDER, Colo., June 12, 2017 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Boulder, CO, USA) and Positive Bioscience (Mumbai, India) announced today that they have entered into an agreement where Positive...
22. Mai 2017 13:31 ET | Quelle: Biodesix, Inc.

New Study Shows Advanced Diagnostic Tests, Including the VeriStrat® Test, Can Help Physicians Improve Cancer Care Planning and Reach Quality Measures For Patients

BOULDER, Colo., May 22, 2017 (GLOBE NEWSWIRE) -- Today, Biodesix®, Inc. will present the results of a new study demonstrating that VeriStrat testing and other tools can help physicians improve...
05. April 2017 08:00 ET | Quelle: Biodesix, Inc.

Biodesix Presents Data From Three Studies at AACR Annual Meeting

BOULDER, Colo., April 05, 2017 (GLOBE NEWSWIRE) -- Biodesix is presenting three studies that support the company’s multi-omic capabilities and provide insight into the biology of classifiers...
03. April 2017 13:08 ET | Quelle: Biodesix, Inc.

New Data Show Biodesix’s VeriStrat® Test is Cost-Saving, Improves Survival and Quality of Life in Advanced Lung-Cancer Patients

BOULDER, Colo., April 03, 2017 (GLOBE NEWSWIRE) -- Biodesix®, Inc. announced today new data demonstrating that use of the VeriStrat® test in patients with advanced non-small cell lung cancer (NSCLC)...
22. März 2017 14:03 ET | Quelle: Biodesix

New Study Shows Biodesix’s VeriStrat Changes Treatment Decisions for Lung Cancer Patients; Reduces Over-Treatment at End of Life

BOULDER, Colo., March 22, 2017 (GLOBE NEWSWIRE) -- Biodesix®, Inc. announced today the results of a study demonstrating that the use of the VeriStrat® test for patients with non-small cell lung...

Vorherige Seite

Nächste Seite